TNFRSF9 and neoplasm: The relative distribution of all CD137, TNF, or IFNγ combinations is shown in Figure 2G (tumor-specific reactive CD8+ TILs) and Supplementary Figure 5D (tumor-specific reactive CD4+ TILs).